阿斯利康全球研发北京战略中心启用 加速推进新一代创新药物研发

中国网财经
Oct 25

中国网财经10月25日讯阿斯利康今日在京正式启用全新全球战略研发中心,这是阿斯利康全球第六个、在华第二个战略研发中心。  作为公司25亿美元(约合180亿人民币)投资计划的核心项目,全球研发北京战略中心拥有先进的人工智能和数据科学中心,旨在加速药物早期研究成果向临床开发的转化。  与全球研发上海战略中心协同合作,全球研发北京战略中心将引领新药发现及临床开发工作,加速创新成果转化为改变生命的药物。该...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10